Publications by authors named "Emily Walits"

Background: (), a multidrug-resistant fungus first described in Japan in 2009, has since spread rapidly around the world. More recently, cases of have increased substantially, which may have been affected by the strain the coronavirus disease 2019 (COVID-19) pandemic placed on health care resources. We describe the epidemiology of infection and colonization at a tertiary care hospital in New York City before, during, and after the peak of the COVID-19 pandemic and describe our approach to surveillance.

View Article and Find Full Text PDF

Candida auris is a multidrug-resistant fungus that has led to health care-associated outbreaks globally. Contact investigations for new cases of Candida auris are a recommended infection prevention practice; however, there is limited knowledge and experience with such investigations. We describe our institution's experience from June 2018 through January 2019.

View Article and Find Full Text PDF

Contact precautions are used to prevent the spread of extended-spectrum β-lactamase (ESBL)-producing organisms in acute-care hospitals, but supporting data are lacking. We discontinued such precautions for ESBL and spp and found no increased prevalence of these organisms with our change in practice.

View Article and Find Full Text PDF

The World Health Organization and Centers for Disease Control and Prevention consider the global increase in multidrug-resistant organisms (MDROs) to be one of the greatest modern threats to public health. Limited treatment options exist for microorganisms such as carbapenem-resistant Enterobacterales and Candida auris; as a result, infected patients may experience poor outcomes. Perioperative nurses should use infection prevention measures (eg, contact precautions) to prevent the spread of emerging MDROs when transporting patients to and from procedures, caring for patients during procedures, and completing between-procedure cleaning.

View Article and Find Full Text PDF

Candida auris is an emerging, multidrug-resistant yeast that is considered a threat to patients and health care facilities worldwide. As the incidence of C auris increases, the management of patients with C auris will expand beyond acute care hospitals and long-term care facilities. We discuss the infection prevention measures implemented to prevent the transmission of Candida auris on an inpatient acute rehabilitation unit while ensuring that appropriate patient care was provided.

View Article and Find Full Text PDF